Compare VOC & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VOC | PSNL |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.7M | 872.1M |
| IPO Year | 2011 | 2019 |
| Metric | VOC | PSNL |
|---|---|---|
| Price | $2.81 | $8.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $10.71 |
| AVG Volume (30 Days) | 53.7K | ★ 1.8M |
| Earning Date | 01-01-0001 | 11-04-2025 |
| Dividend Yield | ★ 22.16% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.51 | N/A |
| Revenue | $9,783,812.00 | ★ $69,103,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $20.33 |
| P/E Ratio | $5.58 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.44 | $2.83 |
| 52 Week High | $5.12 | $11.40 |
| Indicator | VOC | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 43.55 | 46.75 |
| Support Level | $2.82 | $7.68 |
| Resistance Level | $2.95 | $9.85 |
| Average True Range (ATR) | 0.08 | 0.59 |
| MACD | -0.01 | -0.23 |
| Stochastic Oscillator | 3.03 | 30.67 |
VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.